These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36951045)

  • 1. Paediatric heart failure - understanding the pathophysiology and the current role of cardiac biomarkers in clinical practice.
    McGinn C; Casey FA; Watson C; Morrison L
    Cardiol Young; 2023 Apr; 33(4):503-513. PubMed ID: 36951045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.
    Cantinotti M; Law Y; Vittorini S; Crocetti M; Marco M; Murzi B; Clerico A
    Heart Fail Rev; 2014 Nov; 19(6):727-42. PubMed ID: 24473828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 5. Is N-terminal pro-brain type natriuretic peptide a useful marker in newborns with heart defects?
    Tarkowska A; Furmaga-Jabłońska W
    Adv Clin Exp Med; 2021 Sep; 30(9):905-912. PubMed ID: 34327879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trending Cardiac Biomarkers During Pregnancy in Women With Cardiovascular Disease.
    Chang SA; Khakh P; Janzen M; Lee T; Kiess M; Rychel V; Grewal J
    Circ Heart Fail; 2022 Aug; 15(8):e009018. PubMed ID: 35904022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of NT-proBNP in children with heart failure younger than 3 years old.
    Iacob D; Butnariu A; Leucuţa DC; Samaşca G; Deleanu D; Lupan I
    Rom J Intern Med; 2017 Jun; 55(2):69-74. PubMed ID: 28118147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of urinary NT-proBNP in ambulatory settings.
    Müller N; Bayer E; Bernhardt C; Breuer J; Freudenthal NJ
    Clin Chim Acta; 2022 Apr; 529():4-9. PubMed ID: 35124002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
    Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
    Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cardiac biomarkers in association with alterations in cardiac structure and function, and health status in heart failure with reduced ejection fraction: the EVALUATE-HF trial.
    Myhre PL; Claggett BL; Shah AM; Prescott MF; Ward JH; Fang JC; Mitchell GF; Solomon SD; Desai AS
    Eur J Heart Fail; 2022 Jul; 24(7):1200-1208. PubMed ID: 35560696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
    Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
    J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
    Bai J; Han L; Liu H
    Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to interpret cardiac biomarkers in children?
    McGinn C; Waterfield T; McKeeman G; Morrison L; Callaghan S; Watson C; Casey FA
    Arch Dis Child Educ Pract Ed; 2023 Aug; 108(4):265-270. PubMed ID: 36414386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
    Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
    ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
    Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
    Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of analysis of H-FABP, NT-proBNP, and cTnI in heart function in children with congenital heart disease and pneumonia.
    Zhou FJ; Zhou CY; Tian YJ; Xiao AJ; Li PL; Wang YH; Jia JW
    Eur Rev Med Pharmacol Sci; 2014; 18(10):1513-6. PubMed ID: 24899611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.